CS
Chris Schott JP Morgan Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
29
Avg Return
Past Year
Past Year
9.5%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
82.8%
Neutral
13.8%
Negative
3.4%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Neutral
Maintained
| $250 |
3%
upside
| 1 | – |
–
| 5 Mar ‘26 4 days ago |
|
|
|
Overweight
Maintained
| $28 |
17%
upside
| 2 | +8.3% |
0
%
| 19 Feb ‘26 18 days ago |
|
|
|
Overweight
Maintained
| $1,300 |
29%
upside
| 4 | +13% |
0
%
| 5 Feb ‘26 1 month ago |
|
|
|
Overweight
Maintained
| $950 |
22%
upside
| 4 | +7.9% |
0
%
| 2 Feb ‘26 1 month ago |
|
|
|
Overweight
Maintained
| $35 |
11%
upside
| 4 | +17% |
0
%
| 16 Dec ‘25 2 months ago |
|
|
|
Neutral
Maintained
| $18 |
75%
upside
| 3 | -36% |
0
%
| 15 Dec ‘25 2 months ago |
|
|
|
Underweight
Maintained
| $12 |
84%
upside
| 1 | +15% |
0
%
| 11 Nov ‘25 3 months ago |
|
|
|
Overweight
Maintained
| $200 |
63%
upside
| 1 | -1.7% |
0
%
| 5 Nov ‘25 4 months ago |
|
|
|
Overweight
Maintained
| $775 |
27%
upside
| 2 | +9.7% |
0
%
| 4 Nov ‘25 4 months ago |
|
|
|
Overweight
Maintained
| $260 |
14%
upside
| 2 | +2.3% |
0
%
| 3 Nov ‘25 4 months ago |
|
|
|
Overweight
Maintained
| $150 |
2%
upside
| 3 | +11% |
0
%
| 31 Oct ‘25 4 months ago |
|
|
|
Overweight
Maintained
| $14 |
6%
upside
| 1 | +35% |
0
%
| 16 Sep ‘25 5 months ago |
|
|
|
Neutral
Maintained
| $175 |
7%
downside
| 1 | – |
–
| 5 May ‘25 10 months ago |
|